Autosomal dominant dopa-responsive parkinsonism in a multigenerational Swiss family

Parkinsonism and Related Disorders

Volumn 14, Issue 6, 2008, Pages 465-470

  Wider, C ^a,b   Skipper, L ^c   Solida, A ^a   Brown, L ^b   Farrer, M ^c   Dickson, D ^b   Wszolek, Z K ^b   Vingerhoets, F J G ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b MAYO CLINIC   (United States)

^c MAYO GRADUATE SCHOOL   (United States)

Author keywords

Autosomal dominant; Familial; Parkinson's disease; Parkinsonism

Indexed keywords

ALPHA SYNUCLEIN; AMANTADINE; ATAXIN 3; BENSERAZIDE PLUS LEVODOPA; BIPERIDEN; CABERGOLINE; CARBIDOPA; CARBIDOPA PLUS LEVODOPA; CYSTEINE PROTEINASE; DOPAMINE RECEPTOR STIMULATING AGENT; FLUORODEOXYGLUCOSE F 18; FRAGILE X MENTAL RETARDATION PROTEIN; LEUCINE RICH REPEAT KINASE 2; LEVODOPA; PARKIN; PROGRANULIN; PROTEIN KINASE; PROTEIN SCA2; PTEN INDUCED KINASE 1; ROPINIROLE; SELEGILINE; TAU PROTEIN; UBIQUITIN THIOLESTERASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AUTOPSY; AUTOSOMAL DOMINANT INHERITANCE; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEMENTIA; DISEASE COURSE; DISEASE SEVERITY; DIZZINESS; DRUG DOSE INCREASE; DRUG DOSE REGIMEN; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEARNING DISORDER; MALE; MENTAL DEFICIENCY; NAUSEA; PARKINSON DISEASE; PARKINSONISM; PEDIGREE; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCHIZOPHRENIA; TREATMENT RESPONSE; TREMOR;

ADULT; AGED; ANTIPARKINSON AGENTS; BRAIN; CHROMOSOME DISORDERS; DIHYDROXYPHENYLALANINE; DNA MUTATIONAL ANALYSIS; FEMALE; GENES, DOMINANT; HUMANS; LEVODOPA; MALE; MIDDLE AGED; MUTATION; PARKINSON DISEASE; PEDIGREE; PHENOTYPE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 49649103203     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2007.11.013     Document Type: Article

References (42)

1. de Rijk M.C., Tzourio C., Breteler M.M., Dartigues J.F., Amaducci L., Lopez-Pousa S., et al. Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the epidemiology of Parkinson's disease. J Neurol Neurosurg Psychiatry 62 1 (1997 Jan) 10-15
2. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276 5321 (1997 Jun 27) 2045-2047
3. Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392 6676 (1998 Apr 9) 605-608
4. Gasser T., Muller-Myhsok B., Wszolek Z.K., Oehlmann R., Calne D.B., Bonifati V., et al. A susceptibility locus for Parkinson's disease maps to chromosome 2p13. Nat Genet 18 3 (1998 Mar) 262-265
5. Singleton A.B., Farrer M., Johnson J., Singleton A., Hague S., Kachergus J., et al. Alpha-synuclein locus triplication causes Parkinson's disease. Science 302 5646 (2003 Oct 31) 841
6. Leroy E., Boyer R., Auburger G., Leube B., Ulm G., Mezey E., et al. The ubiquitin pathway in Parkinson's disease. Nature 395 6701 (1998 Oct 1) 451-452
7. Valente E.M., Abou-Sleiman P.M., Caputo V., Muqit M.M., Harvey K., Gispert S., et al. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304 5674 (2004 May 21) 1158-1160
8. Bonifati V., Rizzu P., van Baren M.J., Schaap O., Breedveld G.J., Krieger E., et al. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299 5604 (2003 Jan 10) 256-259
9. Zimprich A., Biskup S., Leitner P., Lichtner P., Farrer M., Lincoln S., et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44 4 (2004 Nov 18) 601-607
10. Ramirez A., Heimbach A., Grundemann J., Stiller B., Hampshire D., Cid L.F., et al. Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat Genet 38 10 (2006 Oct) 1184-1191
11. Hicks A.A., Petursson H., Jonsson T., Stefansson H., Johannsdottir H.S., Sainz J., et al. A susceptibility gene for late-onset idiopathic Parkinson's disease. Ann Neurol 52 5 (2002 Nov) 549-555
12. Pankratz N., Nichols W.C., Uniacke S.K., Halter C., Rudolf A., Shults C., et al. Genome screen to identify susceptibility genes for Parkinson disease in a sample without parkin mutations. Am J Hum Genet 71 1 (2002 Jul) 124-135
13. Hughes A.J., Daniel S.E., Kilford L., and Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55 3 (1992 Mar) 181-184
14. Vingerhoets F.J., Schulzer M., Ruth T.J., Holden J.E., and Snow B.J. Reproducibility and discriminating ability of fluorine-18-6-fluoro-l-Dopa PET in Parkinson's disease. J Nucl Med 37 3 (1996 Mar) 421-426
15. Branger F. Une forme familiale de paralysieo agitante dans une souche des Grisons. J Genet Hum 5 (1956) 261-270
16. Otto F.G. Ein Beitrag zu familiar gehauft auftretenden Fallen von Parkinsonismus. Nervenarzt 54 (1983) 423-425
17. Klein C., Pramstaller P.P., Kis B., Page C.C., Kann M., Leung J., et al. Parkin deletions in a family with adult-onset, tremor-dominant parkinsonism: expanding the phenotype. Ann Neurol 48 1 (2000 Jul) 65-71
18. Pramstaller P.P., Schlossmacher M.G., Jacques T.S., Scaravilli F., Eskelson C., Pepivani I., et al. Lewy body Parkinson's disease in a large pedigree with 77 Parkin mutation carriers. Ann Neurol 58 3 (2005 Sep) 411-422
19. Baldereschi M., Di C.A., Rocca W.A., Vanni P., Maggi S., Perissinotto E., et al. Parkinson's disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. ILSA Working Group. Italian Longitudinal Study on Aging. Neurology 55 9 (2000 Nov 14) 1358-1363
20. Baba Y., Markopoulou K., Putzke J., Whaley N.R., Farrer M.J., Wszolek Z.K., et al. Phenotypic commonalities in familial and sporadic Parkinson disease. Arch Neurol 63 (2006) 579-583
21. Kimura H., Kurimura M., Wada M., Kawanami T., Kurita K., Suzuki Y., et al. Female preponderance of Parkinson's disease in Japan. Neuroepidemiology 21 6 (2002 Nov) 292-296
22. Josephs K.A., Matsumoto J.Y., and Ahlskog J.E. Benign tremulous parkinsonism. Arch Neurol 63 3 (2006 Mar) 354-357
23. Wszolek Z.K., Gwinn-Hardy K., Wszolek E.K., Muenter M.D., Pfeiffer R.F., Rodnitzky R.L., et al. Neuropathology of two members of a German-American kindred (Family C) with late onset parkinsonism. Acta Neuropathol (Berl) 103 4 (2002 Apr) 344-350
24. Gulcher J.R., Jonsson P., Kong A., Kristjansson K., Frigge M.L., Karason A., et al. Mapping of a familial essential tremor gene, FET1, to chromosome 3q13. Nat Genet 17 1 (1997 Sep) 84-87
25. Higgins J.J., Pho L.T., and Nee L.E. A gene (ETM) for essential tremor maps to chromosome 2p22-p25. Mov Disord 12 6 (1997 Nov) 859-864
26. Farrer M., Gwinn-Hardy K., Muenter M., DeVrieze F.W., Crook R., Perez-Tur J., et al. A chromosome 4 p haplotype segregating with Parkinson's disease and postural tremor. Hum Mol Genet 8 1 (1999 Jan) 81-85
27. Romito L.M., Contarino M.F., Ghezzi D., Franzini A., Garavaglia B., and Albanese A. High frequency stimulation of the subthalamic nucleus is efficacious in Parkin disease. J Neurol 252 2 (2005 Feb) 208-211
28. Schupbach M., Lohmann E., Anheim M., Lesage S., Czernecki V., Yaici S., et al. Subthalamic nucleus stimulation is efficacious in patients with Parkinsonism and LRRK2 mutations. Mov Disord 22 1 (2007 Jan) 119-122
29. Aarsland D., Andersen K., Larsen J.P., Lolk A., and Kragh-Sorensen P. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol 60 3 (2003 Mar) 387-392
30. Hall D.A., Berry-Kravis E., Jacquemont S., Rice C.D., Cogswell J., Zhang L., et al. Initial diagnoses given to persons with the fragile X associated tremor/ataxia syndrome (FXTAS). Neurology 65 2 (2005 Jul 26) 299-301
31. Winter C., Juckel G., Plotkin M., Niehaus L., and Kupsch A. Paranoid schizophrenia and idiopathic Parkinson's disease do coexist: a challenge for clinicians. Psychiatry Clin Neurosci 60 5 (2006 Oct) 639
32. Lam R.W. Chronic schizophrenia and idiopathic Parkinson's disease. Can J Psychiatry 38 2 (1993 Mar) 75-77
33. Vingerhoets F.J., Snow B.J., Lee C.S., Schulzer M., Mak E., and Calne D.B. Longitudinal fluorodopa positron emission tomographic studies of the evolution of idiopathic parkinsonism. Ann Neurol 36 5 (1994 Nov) 759-764
34. van de Warrenburg B.P., Lammens M., Lucking C.B., Denefle P., Wesseling P., Booij J., et al. Clinical and pathologic abnormalities in a family with parkinsonism and parkin gene mutations. Neurology 56 4 (2001 Feb 27) 555-557
35. Wszolek Z.K., Pfeiffer R.F., Tsuboi Y., Uitti R.J., McComb R.D., Stoessl J., et al. Autosomal dominant parkinsonism associated with variable synuclein and tau pathology. Neurology 62 9 (2004 May 11) 1619-1622
36. Paisan-Ruiz C., Jain S., Evans E.W., Gilks W.P., Simon J., van der Brug M., et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 44 4 (2004 Nov 18) 595-600
37. Aasly J.O., Toft M., Fernandez-Mata I., Kachergus J., Hulihan M., White L.R., et al. Clinical features of LRRK2-associated Parkinson's disease in central Norway. Ann Neurol 57 5 (2005 May) 762-765
38. Papapetropoulos S., Singer C., Ross O.A., Toft M., Johnson J.L., Farrer M.J., et al. Clinical heterogeneity of the LRRK2 G2019S mutation. Arch Neurol 63 9 (2006 Sep) 1242-1246
39. Wszolek Z., Vieregge P., Uitti R.J., Gasser T., Yasuhara O., McGeer P., et al. German-Canadian family (family A) with parkinsonism, amyotrophy, and dementia: longitudinal observations. Parkinsonism Relat Disord 3 (1997) 125-139
40. Kruger R., Kuhn W., Muller T., Woitalla D., Graeber M., Kosel S., et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet 18 2 (1998 Feb) 106-108
41. Golbe L.I., Di I.G., Bonavita V., Miller D.C., and Duvoisin R.C. A large kindred with autosomal dominant Parkinson's disease. Ann Neurol 27 3 (1990 Mar) 276-282
42. Zarranz J.J., Alegre J., Gomez-Esteban J.C., Lezcano E., Ros R., Ampuero I., et al. The new mutation, E46 K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 55 2 (2004 Feb) 164-173